Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) - Global Forecasts to 2025
[186 Pages Report] The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period. Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain. Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years.
To know about the assumptions considered for the study, download the pdf brochure
COVID-19 Impact on the global cold pain therapy market
The COVID-19 pandemic has significantly affected the cold pain therapy market. Due to the pandemic, the cold pain therapy market experienced short-term negative growth, which can be attributed to a sharp reduction in access to hospital and retail pharmacies and the temporarily shutdown of orthopedic clinics and rehabilitation centers. The US witnessed a decline of 3060% in hospital visits after the announcement of nationwide lockdown measures (Source: The Commonwealth Fund, 2020). The restricted or limited access to rehabilitation clinics, temporary closure of gyms and fitness centers, restrictions on outdoor sporting activities, and social distancing measures resulted in a reduction in the number of trauma and sports injuries. This further reduced the sales of cold pain therapy products. With the reopening of hospitals, clinics, and sports institutions and relaxations in lockdown measures, growth in this market is expected to pick up pace in the coming months.
Moreover, the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products (such as cold gel packs, ointments, and cold sprays) for pain management are some of the key factors likely to drive the long-term growth of the cold pain therapy market.
Cold Pain Therapy Market Dynamics
Driver: Increase in the prevalence of incidence of sports injuries
Musculoskeletal injuries are the most common forms of sports-related injuries. Some of the common injuries include ankle sprains, knee injuries, fractures, joint injuries, tennis elbow (epicondylitis), and dislocations. Cold pain therapy products, such as ice packs and sprays, are the most commonly used products for the management of pain associated with sports-related injuries as they provide instant pain relief. Furthermore, with rising disposable income levels, growing health awareness, growing obesity rate, and growing stress levels, the emphasis on gym activities and workouts among adults across the globe has increased augumenting the market growth.
Restraint:High usage of low-priced analgesic pills for immediate pain relief
As the population in emerging nations is price-sensitive, they prefer lower-priced products. Analgesic drugs, such as paracetamol or acetaminophen, ibuprofen, and aspirin, are among the most widely used OTC drugs. These drugs are widely available at lower costs. This, coupled with the low awareness related to the adverse effects of painkillers, is a key factor contributing to the high adoption of analgesic pills for immediate pain relief.
The high adoption of OTC drugs by customers in emerging nations due to the availability of low-priced generic versions of drugs, lack of awareness about new therapies for pain management, and growing health concerns are some additional factors contributing to the high usage of analgesic pills, hampering the market growth.
Opportunity: Growing adoption of analgesic patches
Patches are easy to use and provide a wide range of advantages over traditional parenteral or oral routes as the drug delivery is simple, painless, non-invasive, and convenient. Moreover, they increase patient compliance and satisfaction and provide site-specific dosing. While placed on the skin, patches deliver an analgesic drug at a fixed rate across the dermis. The use of analgesic patches through transdermal drug delivery systems offers various advantages over oral medications.
Challenge: Availability of alternative non-drug/device pain management therapies
Non-drug/device therapy approaches, such as physical therapy/exercise, meditation, relaxation techniques, yoga, cognitive-behavioral therapy (CBT), acupuncture, biofeedback, chiropractic manipulation, the application of heat, ultrasound, compression therapy, and massages are alternative treatment options available for acute and chronic pain management in patients. These alternative therapies are less expensive, easily available, and have fewer side effects. Thus, the adoption of these therapies is usually high among patients for the management of acute and chronic pain. Thus, the rising preference of patients for alternative therapies is likely to become a major challenge for market growth.
By product, OTC product segment is expected to have the largest market share during the forecast period
The large share of this segment is attributed to factors such as the significant increase in the prevalence of musculoskeletal disorders such as osteoarthritis, back and neck pain and rise in arwarness among patients about the growing availability of OTC cold pain therapy products.
Musculoskeletal Disorders accounted for the largest share of the cold pain therapy market, by apalication, in 2020
The growing prevalence of musculoskeletal disorders gloablly and the demand for thecost effective pain relief ptroducts and the growing awareness about the avaolibility of effective cold therapy products for the musculoskeletal disorders pain management and rise in the geriatric patient population are likely to fuel the growth of this segment during the forecast period.
Retail Pharamcies accounted for the largest share of the cold pain therapy market, by Distribution channel, in 2020
The segment accounted for the highest share owing to the increasing growing awareness about the availability of effective cold pain therapy products in retail pharmacies, increase in the expansion of retail pharmacies through collaboration with e-pharacies and the major focus on strengthening the brand connection among customnesr by widening their personal consulatnat services are some of the factors anticipated to preopel the growth of this segment.
North America is the largest regional market for Cold pain therapy
North America (comprising the US and Canada) dominates cold pain therapy market. North America is a gaining traction with the increasing incidence and prevalence of orthopedic disoprders. Moreoer resence of major key platers in the region, facourable government scenarios, higher awarness of self tetsing and home care products and significant adoption of cold therapy products are likely to paly a major role in fueling the growth of the cold pain therapy market in the North America.
Key Market Players
Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Φssur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US)
Sanofi is among the leading pharmaceutical companies in the world. It focuses on the research, development, manufacture, and commercialization of healthcare products (including medicines, vaccines, and therapeutic products). The company operates its business through three segments, namely, Pharmaceuticals, Vaccines, and Consumer Healthcare. Sanofi offers a wide range of cold pain therapy products, such as patches, creams, sprays, balms, and roll-ons,through its Consumer Healthcare segment and its subsidiary Chattem, Inc. (US).Sanofi has a strong geographic presence in over 100 countries, with distribution networks across more than 170 countries across the globe,including the US, France, Germany, Turkey, Brazil, and Japan. Some of its key subsidiaries include Aventis, Inc. (US), Sanofi-Aventis Deutschland GmbH (Germany), Aventis Pharma Limited (UK), Sanofi (Hangzhou) Pharmaceuticals Co., Ltd. (China), and Merial Japan Ltd.
Scope of the report
|
Report Metric |
Details |
|
Market Size Available for Years |
20172025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
20202025 |
|
Forecast Units |
Value (USD Billion) |
|
Segments Covered |
Product, Application, Distribution Channel and Region |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA |
|
Companies Covered |
Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Φssur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US). |
This research report categorizes the cold pain therapy market based on product, application, distribution channel and region.
By Product
- OTC Products
- Pharmaceuticals
- Gels, Ointments, and Creams
- Sprays and Foams
- Patches
- Roll-Ons
- Medical Devices
- Pharmaceuticals
- Cold Packs
- Cooling Towels, Compresses, Wraps, and Pads
- Prescription Products
- Motorized Devices
- Non-Motorized Devices
By Application
- Musculoskeletal Disorders
- Post-Operative Therapy
- Sports Medicine
- Post-Trauma Therapy
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Pharmacies
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Recent Developments
- In 2019, Performance Health announced the launch of Cold Patches Biofreeze Pain Relief Patch
- In 2019, DJO Global introduced the cooling pads DonJoy IceMan CLASSIC3
- In 2018, Hisamitsu Pharmaceutical and Olympic and Paralympic Games, Tokyo 2020 entered into strategic partnership. Hisamitsu became an official partner to provide external pain relief products to the athelets, thus strenthing its brand presence.
Frequently Asked Questions (FAQ):
What are the drivers for the cold pain therapy market?
The increase in the prevalence of sports injury, rise in number of hip and knee surgeries, increase in the demand for cost effective cold pain therapy products, and the increase in number of players in cold therapy producst are likely to drive the market growth.
Which segment provides the most opportunity for growth?
Among products, the OTC cold therapy products will show the most opportunity for growth.
Who are the leading vendors operating in this market?
Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Φssur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US) are the major vendors in the market
Which region is expected to witness significant demand for cold pain therapy in the coming years?
The Asia Pacific is the fastest-growing geographic segment in cold pain therapy market, with a CAGR of 5.6% during the forecast period. Rising healthcare expenditure; emergence of key manufacturers with established portfolio, growing preference of topical products, increasing awareness of different cold pain therapy products are some of the factors anticipated to propel the growth of the APAC cold pain therapy market.
What is the COVID 19 impact on cold pain therapy in the coming years?
The COVID-19 pandemic has affected the cold pain therapy market. Reduction in the sales of the cold pain therapy products were attributed to the reduced access to retail pharamcies and low hospital , orthopedic clinics vist due to the lockdown. However, the reopening of hospitals, clinics, and sports institutions and relaxations in lockdown measures, growth in this market is expected to pick up pace in the coming months. Along with this the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products played a critical role in boosting the sales growth of cold therapy products. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Stakeholders
1.5 Currency
1.6 Scope of the Study
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Data
2.1.2 Primary Data
2.1.2.1 Key Data From Secondary Data
2.2 Market Size Estimation
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Limitations
3 Executive Summary
4 Premium Insights
4.1 Key Drivers in the Market (2018-2023)
4.2 Global Market, By Product 2018 vs 2023 (USD Million)
4.3 Global Market: By Application (2018 vs 2023)
4.4 North America to Hold the Largest Market Share in the Cold Pain Therapy Market in 2018
4.5 Asia-Pacific to Register the Highest CAGR in Market During the Forecast Period (20182023)
5 Market Overview
5.1 Introduction
5.2 Key Market Drivers
5.2.1 Increasing Incidence of Sports Injuries and Rising Emphasis on Exercise and Gym Activities
5.2.2 Growing Number of Hip and Knee Surgeries Across the Globe
5.2.3 Growing Need for Safer Pain Management Modalities as Opposed to Oral Drug Therapy
5.2.4 Clinical Evidence in Favorof Menthol-Based Topical Analgesics
5.3 Key Market Restraints
5.3.1 High Usage of Low-Priced Analgesic Pills for Immediate Pain Relief
5.3.2 Lack of Reimbursement
5.3.3 Lack of Substantial Clinical Evidence in Favor of Cold Pain Therapy
5.3.4 Health Hazards and Discomfort Associated With Cold Pain Therapy Products
5.4 Key Market Opportunities
5.4.1 Growing Adoption of Analgesic Patches Because of the Advantages Associated With the Use of Them
5.4.2 Aging Population Sensitive to Traumatic Injuries
5.4.3 Growing Awareness Among Consumers Owing to Promotional Marketing Strategies
5.4.4 Growing Use of Cold Pain Therapy Among Middle-Aged Women
5.4.5 Increasing Regulatory Barriers for Oral Pain Medications
5.5 Key Market Challenges
5.5.1 Availability of Alternative Non-Drug/Device Pain Management Therapies
5.5.2 Stringent Regulations on Ammonium Nitrate Usage
6 Cold Pain Therapy Market, By Product
6.1 Introduction
6.2 OTC Products
6.2.1 Pharmaceuticals
6.2.1.1 Gels, Ointments, and Creams
6.2.1.2 Sprays and Foams
6.2.1.3 Patches
6.2.1.4 Roll-Ons
6.2.2 Medical Devices
6.2.2.1 Cold Packs
6.2.2.2 Cooling Towels, Compresses, Wraps, and Pads
6.3 Prescription Products
6.3.1 Motorized Devices
6.3.2 Non-Motorized Devices
7 Cold Pain Therapy Market, By Application
7.1 Introduction
7.2 Musculoskeletal Disorders
7.3 Post-Operative Therapy
7.4 Sports Medicine
7.5 Post-Trauma Therapy
8 Cold Pain Therapy Market, By Region
8.1 Global Market
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe (RoE)
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.5 Rest of Asia Pacific (RoAPAC)
8.5 Rest of the World (RoW)
8.5.1 Latin America
8.5.2 Middle East and Africa
9 Competitive Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Competitive Scenario
9.4 Recent Developments
9.4.1 New Product Launches
9.4.2 Agreements, Partnerships, and Contracts
9.4.3 Expansions
10 Company Profiles
10.1 Beiersdorf
10.2 Breg
10.3 Custom Ice
10.4 DJO Finance
10.5 Hisamitsu Pharmaceutical
10.6 Johnson & Johnson
10.7 Medline Industries
10.8 Φssur
10.9 Performance Health
10.1 Pfizer
10.11 Sanofi
10.13 Rohto Pharmaceutical
10.13 Romsons Group of Industries
10.14 Unexo Life Sciences
10.15 3M
11 Appendix
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets Subscription Portal
11.3 Marketsandmarkets Knowledge Store: Snapshot
11.4 Introducing RT: Real Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
List of Tables (106 Tables)
Table 1 Global Cold Pain Therapy Market, By Product, 20162023 (USD Million)
Table 2 Market for OTC Products, By Type, 20162023 (USD Million)
Table 3 Market for OTC Products, By Region, 20162023 (USD Million)
Table 4 Market Size for Pharmaceuticals, By Type 20162023 (USD Million)
Table 5 Market Size for Pharmaceuticals Market, By Region, 20162023 (USD Million)
Table 6 Market Size for Gels, Ointments, and Creams Market, By Region, 20162023 (USD Million)
Table 7 Cold Pain Therapy Market Size for Sprays & Foams Market, By Region, 20162023 (USD Million)
Table 8 Market Size Patches Market, By Region, 20162023 (USD Million)
Table 9 Market Size for Roll-Ons Market, By Region, 20162023 (USD Million)
Table 10 Market Size for Medical Devices Market, By Type, 20162023 (USD Million)
Table 11 Market Size for Medical Devices Market, By Region, 20162023 (USD Million)
Table 12 Cold Pain Therapy Market Size for Cold Packs Market, By Region, 20162023 (USD Million)
Table 13 Market Size for Cold Compresses, Wraps, and Pads Market, By Region, 20162023 (USD Million)
Table 14 Market Size for Prescription Products, By Type, 20162023 (USD Million)
Table 15 Market for Prescription Products, By Region, 20162023 (USD Million)
Table 16 Market Size for Motorized Devices Market, By Region, 20162023 (USD Million)
Table 17 Market Size for Non-Motorized Devices Market, By Region, 20162023 (USD Million)
Table 18 Market, By Application, 20162023 (USD Million)
Table 19 Market for Musculoskeletal Disorders, By Region, 20162023 (USD Million)
Table 20 Market for Post-Operative Therapy, By Region, 20162023 (USD Million)
Table 21 Market for Sports Medicine, By Region, 20162023 (USD Million)
Table 22 Market for Post-Trauma Therapy, By Region, 20162023 (USD Million)
Table 23 Market, By Region, 20162023 (USD Million)
Table 24 North America: Market, By Country, 20162023 (USD Million)
Table 25 North America: Market, By Product, 20162023 (USD Million)
Table 26 North America: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 27 North America: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 28 North America: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 29 North America: Market, By Application, 20162023 (USD Million)
Table 30 US: Market, By Product, 20162023 (USD Million)
Table 31 US: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 32 US: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 33 US: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 34 Canada: Market, By Product, 20162023 (USD Million)
Table 35 Canada: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 36 Canada: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 37 Canada: Market for Prescription Products, 20162023 (USD Million)
Table 38 Europe: Market, By Country, 20162023 (USD Million)
Table 39 Europe: Market, By Product, 20162023 (USD Million)
Table 40 Europe: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 41 Europe: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 42 Europe: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 43 Europe: Market, By Application, 20162023 (USD Million)
Table 44 Germany: Market, By Product, 20162023 (USD Million)
Table 45 Germany: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 46 Germany: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 47 Germany: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 48 UK: Market, By Product, 20162023 (USD Million)
Table 49 UK: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 50 UK: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 51 UK: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 52 France: Market, By Product, 20162023 (USD Million)
Table 53 France: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 54 France: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 55 France: Cold Pain Therapy Market for Prescription Products, By Type, 20162023 (USD Million)
Table 56 Spain: Market, By Product, 20162023 (USD Million)
Table 57 Spain: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 58 Spain: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 59 Spain: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 60 Italy: Market, By Product, 20162023 (USD Million)
Table 61 Italy: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 62 Italy: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 63 Italy: Market Size for Prescription Products, By Type, 20162023 (USD Million)
Table 64 RoE: Market Size, By Product, 20162023 (USD Million)
Table 65 RoE: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 66 RoE: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 67 RoE: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 68 Asia Pacific: Market, By Country, 20162023 (USD Million)
Table 69 Asia Pacific: Market, By Product, 20162023 (USD Million)
Table 70 Asia Pacific: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 71 Asia Pacific: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 72 Asia Pacific: Cold Pain Therapy Market for Prescription Products, By Type, 20162023 (USD Million)
Table 73 Asia Pacific: Market, By Application, 20162023 (USD Million)
Table 74 Japan: Market, By Product, 20162023 (USD Million)
Table 75 Japan: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 76 Japan: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 77 Japan: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 78 China: Market, By Product, 20162023 (USD Million)
Table 79 China: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 80 China: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 81 India: Market, By Product, 20162023 (USD Million)
Table 82 India: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 83 India: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 84 India: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 85 Rest of Asia Pacific: Market, By Product, 20162023 (USD Million)
Table 86 Rest of Asia Pacific: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 87 Rest of Asia Pacific: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 88 Rest of Asia Pacific: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 89 RoW: Market, By Country, 20162023 (USD Million)
Table 90 RoW: Market, By Product, 20162023 (USD Million)
Table 91 RoW: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 92 RoW: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 93 RoW: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 94 RoW: Cold Pain Therapy Market, By Application, 20162023 (USD Million)
Table 95 Latin America: Market, By Product, 20162023 (USD Million)
Table 96 Latin America: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 97 Latin America: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 98 Latin America: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 99 Middle East and Africa: Market, By Product, 20162023 (USD Million)
Table 100 Middle East and Africa: OTC Products Market for Pharmaceuticals, By Type, 20162023 (USD Million)
Table 101 Middle East and Africa: OTC Products Market for Medical Devices, By Type, 20162023 (USD Million)
Table 102 Middle East and Africa: Market for Prescription Products, By Type, 20162023 (USD Million)
Table 103 New Product Launches (20142018)
Table 104 Agreements, Partnerships, and Contracts (20142018)
Table 105 Acquisitions (2014-2018)
Table 106 Expansions (20142018)
List of Figures (126 Figures)
Figure 1 Research Design
Figure 2 Top-Down Approach
Figure 3 Top Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Market Share, By Product (2018)
Figure 6 OTC Market Size for Pharmaceuticals Market, By Type, USD Million (2018)
Figure 7 Market Size for Medical Devices, By Product, USD Million (2018)
Figure 8 Market Share for Prescription Products, By Type (2018)
Figure 9 Market Share, By Application (2018)
Figure 10 Global Market to Offer Significant Growth Opportunities to Major Stakeholders During the Next Decade
Figure 11 OTC Products to Dominate the Cold Pain Therapy Market in 2018
Figure 12 Musculoskeletal Disorders Application Segment to Dominate the Market in 2018
Figure 13 North America to Hold the Largest Market Share in the Market in 2018
Figure 14 Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 15 Number of Hip and Knee Replacement Surgeries, By Country (2015)
Figure 16 Number of Deaths Due to Overdose of Opioid Pain Relievers in the US (20102015)
Figure 17 Global Market, By Product (2018)
Figure 18 Market Share for OTC Products, By Type (2018)
Figure 19 Market Share for OTC Products, By Region (2018)
Figure 20 Market Share for Pharmaceuticals, By Type 20162023 (USD Million)
Figure 21 Market Share for Pharmaceuticals Market, By Region (2018)
Figure 22 Market Share for Gels, Ointments, and Creams Market, By Region (2018)
Figure 23 Market Share for Sprays & Foams Market, By Region (2018)
Figure 24 Market Share Patches Market, By Region (2018)
Figure 25 Market Share for Roll-Ons Market, By Region (2018)
Figure 26 Market Share for Medical Devices Market, By Type (2018)
Figure 27 Market Share for Medical Devices Market, By Region, 2018
Figure 28 Market Share for Cold Packs Market, By Region (2018)
Figure 29 Market Share for Cold Compresses, Wraps, and Pads Market, By Region (2018)
Figure 30 Market Share for Prescription Products, By Type (2018)
Figure 31 Market Share for Prescription Products, By Region (2018)
Figure 32 Market Share for Motorized Devices Market, By Region (2018)
Figure 33 Market Share for Non-Motorized Devices Market, By Region (2018)
Figure 34 Market Share, By Application (20182023)
Figure 35 Market Share for Musculoskeletal Disorders, By Region (2018)
Figure 36 Market Share for Post-Operative Therapy, By Region (2018)
Figure 37 Market Share for Sports Medicine, By Region (2018)
Figure 38 Market Share for Post-Trauma Therapy, By Region (2018)
Figure 39 Market Share, By Region (2018)
Figure 40 North America: Cold Pain Therapy Market: Expected Trends (2018 vs 2023)
Figure 41 North America: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 42 North America: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 43 North America: Market Share for Prescription Products, By Type (2018)
Figure 44 North America: Market Share, By Application (2018)
Figure 45 US: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 46 US: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 47 US: Market Share for Prescription Products, By Type (2018)
Figure 48 Canada: Market Share, By Product (2018)
Figure 49 Canada: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 50 Canada: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 51 Canada: Market Share for Prescription Products, By Type (2018)
Figure 52 European Market: Expected Trends (2018 vs 2023)
Figure 53 Europe: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 54 Europe: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 55 Europe: Market Share for Prescription Products, By Type (2018)
Figure 56 Europe: Market Share, By Application (2018)
Figure 57 Germany: Market Share, By Product (2018)
Figure 58 Germany: OTC Products Market for Pharmaceuticals, By Type (2018)
Figure 59 Germany: OTC Products Market for Medical Devices, By Type (2018)
Figure 60 Germany: Market Share for Prescription Products, By Type (2018)
Figure 61 UK: Market Share, By Product (2018)
Figure 62 UK: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 63 UK: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 64 UK: Market Share for Prescription Products, By Type (2018)
Figure 65 France: Market Share, By Product (2018)
Figure 66 France: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 67 France: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 68 France: Cold Pain Therapy Market Share for Prescription Products, By Type (2018)
Figure 69 Spain: Market Share, By Product (2018)
Figure 70 Spain: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 71 Spain: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 72 Spain: Market Share for Prescription Products, By Type (2018)
Figure 73 Italy: Market Share, By Product (2018)
Figure 74 Italy: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 75 Italy: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 76 Italy: Market Share for Prescription Products, By Type (2018)
Figure 77 RoE: Market Share, By Product (2018)
Figure 78 RoE: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 79 RoE: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 80 RoE: Market Share for Prescription Products (2018)
Figure 81 Asia Pacific: Cold Pain Therapy Products Market (2018 vs 2023)
Figure 82 Asia Pacific: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 83 Asia Pacific: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 84 Asia Pacific: Cold Pain Therapy Market Share for Prescription Products, By Type (2018)
Figure 85 Asia Pacific: Market Share, By Application (2018)
Figure 86 Japan: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 87 Japan: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 88 Japan: Market Share for Prescription Products, By Type (2018)
Figure 89 China: Market Share, By Product (2018)
Figure 90 China: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 91 China: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 92 China: Market Share for Prescription Products, By Type (2018)
Figure 93 India: Market Share, By Product (2018)
Figure 94 India: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 95 India: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 96 India: Market Share for Prescription Products, By Type (2018)
Figure 97 RoAPAC: Market Share, By Product (2018)
Figure 98 Rest of Asia Pacific: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 99 Rest of Asia Pacific: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 100 Rest of Asia Pacific: Cold Pain Therapy Market Share for Prescription Products, By Type (2018)
Figure 101 RoW Cold Pain Therapy Products Market (2018 vs 2023)
Figure 102 RoW: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 103 RoW: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 104 RoW: Cold Pain Therapy Market Share for Prescription Products, By Type (2018)
Figure 105 RoW: Market Share, By Application (2018)
Figure 106 Latin America: Market Share, By Product (2018)
Figure 107 Latin America: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 108 Latin America: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 109 Latin America: Market Share for Prescription Products, By Type (2018)
Figure 110 Middle East and Africa: Market Share, By Product (2018)
Figure 111 Middle East and Africa: OTC Products Market Share for Pharmaceuticals, By Type (2018)
Figure 112 Middle East and Africa: OTC Products Market Share for Medical Devices, By Type (2018)
Figure 113 Middle East and Africa: Cold Pain Therapy Market Share for Prescription Products, By Type (2018)
Figure 114 New Product Launches Was the Most Widely Adopted Growth Strategy
Figure 115 Cold Pain Therapy Pharmaceuticals Market Share, By Key Player (2017)
Figure 116 Ranking of Key Players in the Prescription Cold Pain Therapy Medical Devices Market (2017)
Figure 117 Ranking of Key Players in the Cold Pain Therapy Medical Devices Market (2017)
Figure 118 Beiersdorf Company Snapshot (2017)
Figure 119 DJO Finance: Company Snapshot (2017)
Figure 120 Hisamitsu Pharmaceutical: Company Snapshot (2017)
Figure 121 Johnson & Johnson: Company Snapshot (2017)
Figure 122 Φssur: Company Snapshot (2017)
Figure 123 Pfizer: Company Snapshot (2017)
Figure 124 Sanofi: Company Snapshot (2017)
Figure 125 Rohto Pharmaceutical: Company Snapshot (2017)
Figure 126 3M: Company Snapshot (2017)
The study involved four major activities to estimate the current size of the Cold pain therapy market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD),were referred to identify and collect information for the cold pain therapy market study.
Primary Research
he cold pain therapy market comprises several stakeholders such as manufacturers of OTC and prescription cold therapy products, orthopaedic clinics, physiotherapy clinics, sports institutes and organizations, medical research academic institutes, market research and consulting firms. The demand side of this market is characterized by the increasing incidence of musculoskeletal disorders, growing availability of the cold therapy products and increased in number of players in the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cold pain therapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall size of the global Cold pain therapy market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Report Objectives
- To define, describe, and forecast the global cold pain therapy market on the basis of product, platform, mode of purchase, end user, and region.
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
- To profile the key market players and comprehensively analyze their market shares and core competencies2
- To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global cold pain therapy market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your companys specific needs. The following customization options are available for the global Cold pain therapy market report
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players.
Company Information
- Detailed analysis and profiling of additional market players (up to 5 OEMs)
Geographic Analysis
- Further breakdown of the Rest of Europe Cold pain therapy market into Belgium, Austria,
- Denmark, Greece, Poland, and Russia, among other countries
- Further breakdown of the Rest of Asia Pacific Cold pain therapy market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
- Further breakdown of the Rest of Latin America Cold pain therapy market into Argentina, and Colombia, among other countries.
Get in-depth analysis of the COVID-19 impact on the Cold Pain Therapy Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Cold Pain Therapy Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Cold Pain Therapy Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Cold Pain Therapy Market